Print Page | Close Window

Pfizer-vaccine $110-130 per dose

Printed From: Avian Flu Talk
Category: Main Forums
Forum Name: Latest News
Forum Description: (Latest Breaking News)
URL: http://www.avianflutalk.com/forum_posts.asp?TID=45029
Printed Date: April 23 2024 at 5:17am


Topic: Pfizer-vaccine $110-130 per dose
Posted By: Dutch Josh
Subject: Pfizer-vaccine $110-130 per dose
Date Posted: October 28 2022 at 3:06am

[url]https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-price-covid-vaccine-110-130-per-dose-2022-10-20/[/url] or https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-price-covid-vaccine-110-130-per-dose-2022-10-20/ - https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-price-covid-vaccine-110-130-per-dose-2022-10-20/ ;

NEW YORK, Oct 20 (Reuters) - Pfizer Inc expects to roughly quadruple the price of its COVID-19 vaccine to about $110 to $130 per dose after the United States government's current purchase program expires, Pfizer executive Angela Lukin said on Thursday.

Lukin said she expects the vaccine - currently provided for free to all by the government - will be made available at no cost to people who have private insurance or government paid insurance.


Reuters earlier on Thursday reported that Wall Street was expecting such price hikes due to weak demand for COVID vaccines, which meant vaccine makers would need to hike prices to meet revenue forecasts for 2023 and beyond.

NEW YORK, Oct 20 (Reuters) - Pfizer Inc expects to roughly quadruple the price of its COVID-19 vaccine to about $110 to $130 per dose after the United States government's current purchase program expires, Pfizer executive Angela Lukin said on Thursday.

Lukin said she expects the vaccine - currently provided for free to all by the government - will be made available at no cost to people who have private insurance or government paid insurance.


Reuters earlier on Thursday reported that Wall Street was expecting such price hikes due to weak demand for COVID vaccines, which meant vaccine makers would need to hike prices to meet revenue forecasts for 2023 and beyond.

The U.S. government currently pays around $30 per dose to Pfizer and German partner BioNTech SE (22UAy.DE). In 2023, the market is expected to move to private insurance after the U.S. public health emergency expires.

DJ..."for profit media" reporting on "for profit"vaccines in a "for profit" pandemic....The illness is NOT only the virus...it is the "everything for profits" sick system...Why solve a problem if that is bringing in profit...



-------------
We cannot solve our problems with the same thinking we used when we created them.
~Albert Einstein



Print Page | Close Window